MedPath

Safety and Efficacy of Natalizumab in Combination With Remicade in the Treatment of Crohn's Disease

Phase 2
Completed
Conditions
Crohn's Disease
Registration Number
NCT00055536
Lead Sponsor
Biogen
Brief Summary

The purpose of this study is to determine the safety, tolerability, and efficacy of natalizumab in individuals diagnosed with active Crohn's Disease that are not in remission (CDAI greater than/equal to 150) and are currently taking Remicade. It is thought that natalizumab may stop the movement of certain cells, known as white blood cells, into bowel tissue. These cells are thought to cause damage in the bowel leading to the symptoms of Crohn's disease.

Patients who complete this study may be eligible for long-term natalizumab therapy via extension protocol ELN100226-351.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (18)

Wake Research Associates

๐Ÿ‡บ๐Ÿ‡ธ

Raleigh, North Carolina, United States

University of Kentucky Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Lexington, Kentucky, United States

Memphis Gastroenterology Group

๐Ÿ‡บ๐Ÿ‡ธ

Memphis, Tennessee, United States

Digestive Disease Associates

๐Ÿ‡บ๐Ÿ‡ธ

Gainesville, Florida, United States

Borland Groover Clinic

๐Ÿ‡บ๐Ÿ‡ธ

Jacksonville, Florida, United States

Internal Medicine Associates

๐Ÿ‡บ๐Ÿ‡ธ

Danville, Virginia, United States

Massachusetts General Hospital

๐Ÿ‡บ๐Ÿ‡ธ

Boston, Massachusetts, United States

Virginia Mason Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Seattle, Washington, United States

Gastroenterology Consultants

๐Ÿ‡บ๐Ÿ‡ธ

Virginia Beach, Virginia, United States

Atlanta Gastroenterology Associates

๐Ÿ‡บ๐Ÿ‡ธ

Atlanta, Georgia, United States

Asheville Gastroenterology

๐Ÿ‡บ๐Ÿ‡ธ

Asheville, North Carolina, United States

Mercury Street Medical

๐Ÿ‡บ๐Ÿ‡ธ

Butte, Montana, United States

Long Island Clinical Research Associates, LLP

๐Ÿ‡บ๐Ÿ‡ธ

Great Neck, New York, United States

Boice-Willis Clinic

๐Ÿ‡บ๐Ÿ‡ธ

Rocky Mount, North Carolina, United States

Columbia Gastroenterology Associates

๐Ÿ‡บ๐Ÿ‡ธ

Columbia, South Carolina, United States

Gastroenterology Center of the MidSouth

๐Ÿ‡บ๐Ÿ‡ธ

Memphis, Tennessee, United States

Austin Gastroenterology

๐Ÿ‡บ๐Ÿ‡ธ

Austin, Texas, United States

Digestive Health Specialists

๐Ÿ‡บ๐Ÿ‡ธ

Tacoma, Washington, United States

ยฉ Copyright 2025. All Rights Reserved by MedPath